Things become less straightforward when minority shareholders do not fully subscribe. For the most part, shares left untaken, commonly referred to as excess rights shares, are reallocated. Major shareholders may apply for these excess shares to ensure the fundraising succeeds, although such allocations are not automatic.
It’s one of the more uncomfortable positions a listed company can find itself in: doing exactly what it believed it was advised to do, raising the capital it said it would raise, and still being told thereafter that it had crossed a regulatory line. The irony of it all is that this outcome arose not from a complex or novel transaction, but from one of the most familiar fundraising exercises in capital markets.
A rights issue is generally regarded as one of the more straightforward forms of equity fundraising. Existing shareholders are offered discounted new shares in proportion to their holdings, allowing them to maintain their ownership while the company raises cash. Shareholders can take up their rights, sell them, or let them lapse. The mechanics are well-worn and the outcome is meant to be clear-cut.
